Physician profile
William Oslund
NPI 1437680055
$3,815.89
in general payments reported to CMS, 2019-2025
8 companies · $1,319 in 2025
The $1,319 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $224 · 2022: $1,153 · 2023: $161 · 2024: $960 · 2025: $1,319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,706 · Travel and Lodging: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,705.78 |
| Travel and Lodging | $733.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artivion, INC. | $797.51 | 2025 | Amds-Ascyrus Medical |
| Edwards Lifesciences Corporation | $770.96 | 2021-2025 | Konect Resilia |
| Atricure, INC. | $721.86 | 2022-2025 | Synergy Ablation System |
| Stryker Corporation | $442.14 | 2022-2024 | Na |
| Medtronic, INC. | $426.88 | 2022-2025 | Corevalve Evolut R, Vitalflow Console, Freestyle |
| Bolton Medical INC | $264.29 | 2025 | Thoraflex Hybrid, Treo Abdominal Stent-Graft System |
| W. L. Gore & Associates, INC. | $231.49 | 2024 | Gore Tag Thoracic Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft |
| Abbott Laboratories | $160.76 | 2024 | Epic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Oslund listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.